Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01923701 · ClinicalTrials.gov registry record · NA
Cognitive Behavioral Therapy for the Prevention of Paranoia in Adolescents at High Risk
A NA study, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT01923701 is a NA study that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 13 participants.
The verdict
NCT01923701, a NA study, has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
The main objective of this study is to decrease the severity of symptoms and improve psycho-social functioning in youth at high risk of developing psychosis by providing a specialized Group-and-Family-based Cognitive Behavioral Therapy (GF-CBT).
Interventions
- BEHAVIORAL Cognitive Behavioral Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2012-10 |
| Est. Completion | 2018-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01923701
The ClinicalTrials.gov registry entry for NCT01923701 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cognitive Behavioral Therapy is the first listed.
NCT01923701 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01923701 about?
NCT01923701 is a clinical study titled "Cognitive Behavioral Therapy for the Prevention of Paranoia in Adolescents at High Risk". The main objective of this study is to decrease the severity of symptoms and improve psycho-social functioning in youth at high risk of developing psychosis by providing a specialized Group-and-Family-based Cognitive Behavioral Therapy (GF-CBT).
What is the current status of trial NCT01923701?
This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2012-10. Estimated completion is 2018-09.
What interventions are being tested in trial NCT01923701?
The interventions under investigation include: Cognitive Behavioral Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT01923701?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.